Web conference
Tuesday, March 24th, 2026
Virtual event
Despite increasingly structured healthcare pathways and high-level medical expertise in France, the management of patients with rare cancers can still face certain challenges. Using the example of rare head and neck cancers, this roundtable will highlight France’s strengths — organization, expert centers, recognized specialists, multidisciplinary consultations, etc. — as well as its weaknesses — delays in access to care and diagnostics despite urgent needs, territorial heterogeneity of healthcare pathways, integration of therapeutic innovations — in order to identify operational levers.
In short, how does a rare disease underscore broader barriers to patient care in oncology? And how can advances in the field of rare cancer treatment more broadly address identified needs in oncology?
To answer these questions, recognized specialists in head and neck cancers, a patient representative, and an oncology sector representative will speak at a roundtable organized by Pharmaceutiques. This will be followed by a focus on medical and clinical research in oncology, and the importance of collaboration between industry and expert centers.
9:30-10:15: Roundtable
INNOVATION IN PRACTICE
Moderator: Fabien NIZON, Journalist, Pharmaceutiques
- Pr Bertrand BAUJAT, ENT Surgeon, Tenon Hospital (AP-HP), Secretary of the French expert network for rare head and neck cancers (REFCOR)
- Dr Héloïse de KERMADEC, ENT and cervicofacial surgeon at Gustave Roussy
- Dr Caroline EVEN, Medical Oncologist at Gustave Roussy
- Sabrina LE BARS, Co-founder and President of CORasso
10:20-10:40: Focus
CLINICAL RESEARCH ON RARE CANCERS
Moderator: Fabien NIZON, Journalist, Pharmaceutiques
- Dr Yungan TAO, Oncoradiation specialist at Gustave Roussy, President-Elect of GORTEC (Head and Neck Radiotherapy Oncology Group)
- A representative from Unicancer (pending confirmation)
(*) awaiting confirmation
Register HERE
